First deadline to file a gadolinium lawsuit approaching soon
Gadolinium lawyers representing patients who developed the disease nephrogenic systemic fibrosis after receiving an MRI with contrast dye say that time may be running out for some individuals to file a gadolinium lawsuit in their case. According to these attorneys, the first statute of limitations deadline for some gadolinium lawsuit will pass on June 6, 2008. After this date, some patients who developed nephrogenic systemic fibrosis due to gadolinium exposure may lose their legal right to file a lawsuit.
Gadolinium is a heavy metal that is added to MRI contrast dyes in order to make it easier to see organs and body tissues. Because gadolinium is highly toxic, it has to be coated with a special material before it can be safely used in an MRI contrast scan. However, patients with kidney problems can sometimes have difficulty in ridding their bodies of gadolinium as quickly as those with healthy kidneys.
When patients with kidney problems are unable to quickly rid their bodies of an MRI contrast dye containing gadolinium, they can develop a condition known as nephrogenic systemic fibrosis. Patients who develop this disease can experience a tightening of the skin that makes it difficult to extend joints or walk, as well as rashes or patches on the skin.
Patients who received an MRI contrast scan with one of the five gadolinium dyes sold in the U.S. (Magnevist, Omniscan, OptiMARK, MultiHance and Prohance) may wish to contact a gadolinium attorney to learn more about the statues of limitations for filing a gadolinium lawsuit and whether they may still be eligible to file a case.